Twenty-one new fellows have been elected to the Australian Academy of Science. [ + ]

A team of international researchers has moved a step closer to developing a vaccine to protect against middle ear infection, which could also be used for those with poor lung function. [ + ]

The distribution of cold-blooded creatures such as insects, spiders and skinks is predicted to shift rapidly due to extreme weather events associated with climate change. [ + ]

The federal government last week released a statement on the Pharmaceutical Patents Review report, confirming it "has no plans to respond to the report at this stage". [ + ]

Oil spills, such as the 2010 Deepwater Horizon spill in the Gulf of Mexico, cause heart defects in developing fish embryos.  [ + ]

CanTx, a JV between Novogen (ASX:NRT) and Yale University, said its lead drug candidate Trx-1 induced an anti-tumoural effect in a mouse model of ovarian cancer. [ + ]

Prima BioMed (ASX:PRR) has chosen three gynaecological oncology experts to join its clinical advisory board as it prepares for a new trial of CVac in epithelial ovarian cancer. [ + ]

GE Healthcare has completed its acquisition of three businesses from Thermo Fisher Scientific: HyClone cell culture media, Dharmacon RNAi gene modulation and Sera-Mag magnetic beads. [ + ]

The Australian Academy of Science has announced the election of 21 leaders in Australian science to its Fellowship. [ + ]

Genetic Technologies (ASX:GTG) has reached a deal to license its genomic mapping patents to US-based Promega Corporation. [ + ]

Sirtex Medical (ASX:SRX) has signed an agreement to evaluate using its SIR-Spheres microspheres in conjunction with Guerbet's Lipidol to treat a range of liver cancers. [ + ]

After the US FDA approved the first-of-its-kind hearing device, Cochlear has launched a new hybrid hearing solution that helps people's hearing by amplifying low-frequency hearing and restoring access to high-frequency hearing, and will open up new opportunities in the US market. [ + ]

Clinical-stage biotechnology company Patrys has released an update on the development program for its anticancer product PAT-LM1. The company's most recent laboratory experiments evaluated the efficacy of PAT-LM1 in blood cancers, including different types of leukaemias and lymphomas. [ + ]

An international research project has uncovered new evidence about the formation of Earth. The study is the result of more than 10 years' work by scientists from Monash University, The University of Melbourne, the University of Southern California and the Geological Survey of Victoria. [ + ]

This year's Prime Minister's Prizes for Science are open for nominations. [ + ]